Published Online: Tuesday, July 1, 2008

The National Community Pharmacists Association (NCPA) and the International Academy of Compounding Pharmacists (IACP) are joining forces to increase the legislative and regulatory effectiveness of pharmacists who engage in compounding.

"The federal government has shown a proclivity for pursuing and adopting unwarranted and unnecessary policies when it comes to pharmacy compounding as was recently demonstrated by their arbitrary ban of estriol in compounded medications for bioidentical hormone replacement therapy," said Bruce T. Roberts, RPh, NCPA executive vice president and chief executive officer. "NCPA and IACP are committed to joining forces whenever possible to ensure patient access to medications created through compounding is not endangered."

In addition to the estriol battle, both groups have been aligned in numerous other areas in the past and are likely to be in the future. For instance, in 2007, both groups fought back 3 separate attempts in Congress to assume the current responsibility of the State Boards of Pharmacies in regulating certain aspects of pharmacy compounding.

Latest Articles
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.
Police and a CVS pharmacy are on the lookout for a man who stole several boxes of diabetic test strips.
Latest Issues